phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide has been researched along with Disease Models, Animal in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (22.22) | 18.2507 |
2000's | 3 (33.33) | 29.6817 |
2010's | 3 (33.33) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
Authors | Studies |
---|---|
Andrzejewski, K; Kaczyńska, K; Wojciechowski, P | 1 |
Bihel, F; Boon, P; Bourguignon, JJ; Buffel, I; De Herdt, V; De Meulenaere, V; Meurs, A; Poppe, L; Portelli, J; Raedt, R; Schmitt, M; Simonin, F; Smolders, I; Vonck, K; Wadman, W | 1 |
Ancel, C; Beltramo, M; Ben Boujema, M; Bertin, I; Bihel, F; Bourguignon, JJ; Bucher, B; Elhabazi, K; Humbert, JP; Ilien, B; Laboureyras, E; Meziane, H; Petit-Demoulière, B; Quillet, R; Schmitt, M; Schneider, E; Schneider, S; Simonin, F; Simonneaux, V; Simonnet, G; Sorg, T; Utard, V | 1 |
Bajpai, A; Bertozzi, F; Gardell, LR; Gaubert, G; Jacobi, PM; Kelly, N; Lameh, J; Nguyen, D; Olsson, R | 1 |
Iadarola, MJ; Yang, HY | 1 |
Casini, A; D'Este, L; Pontieri, FE; Renda, TG | 1 |
Coudoré-Civiale, MA; Courteix, C; Eschalier, A; Fialip, J; Privat, AM; Zajac, JM | 1 |
Kalso, E; Kontinen, VK; Panula, P; Xu, M | 1 |
Austin, CP; Bomford, D; Clements, MK; Evans, J; Figueroa, D; Gould, R; Guan, XM; Jacobson, M; Jiang, Q; Liu, Q; Mallee, J; Martin, WJ; McDonald, TP; Wang, R; Williams, DL; Yu, H; Zeng, Z | 1 |
1 review(s) available for phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide and Disease Models, Animal
Article | Year |
---|---|
Modulatory roles of the NPFF system in pain mechanisms at the spinal level.
Topics: Amino Acid Sequence; Analgesia; Animals; Disease Models, Animal; Humans; Inflammation; Molecular Sequence Data; Narcotic Antagonists; Oligopeptides; Pain; Receptors, Neuropeptide; Sequence Alignment; Spinal Cord | 2006 |
8 other study(ies) available for phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide and Disease Models, Animal
Article | Year |
---|---|
Intracerebroventricular Neuropeptide FF Diminishes the Number of Apneas and Cardiovascular Effects Produced by Opioid Receptors' Activation.
Topics: Analgesia; Analgesics, Opioid; Animals; Apnea; Cardiovascular Diseases; Disease Models, Animal; Humans; Infusions, Intraventricular; Oligopeptides; Pain Perception; Rats; Receptors, Neuropeptide; Receptors, Opioid, mu; Transcriptional Activation | 2020 |
The effect of neuropeptide FF in the amygdala kindling model.
Topics: Amygdala; Animals; Anticonvulsants; Disease Models, Animal; Epilepsy, Temporal Lobe; Kindling, Neurologic; Male; Oligopeptides; Rats; Rats, Wistar; Seizures | 2016 |
RF313, an orally bioavailable neuropeptide FF receptor antagonist, opposes effects of RF-amide-related peptide-3 and opioid-induced hyperalgesia in rodents.
Topics: Administration, Oral; Analgesics, Opioid; Animals; CHO Cells; Cricetinae; Cricetulus; Disease Models, Animal; Fentanyl; Humans; Hyperalgesia; Male; Mesocricetus; Mice; Mice, Inbred C57BL; Narcotic Antagonists; Oligopeptides; Peptides; Piperidines; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide; Valine | 2017 |
Neuropeptide FF receptors have opposing modulatory effects on nociception.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclic AMP; Disease Models, Animal; Hyperalgesia; Ligands; Male; Mice; Mononeuropathies; NIH 3T3 Cells; Oligopeptides; Pain Measurement; Pain Threshold; Rats; Receptors, Neuropeptide; Small Molecule Libraries; Transfection | 2010 |
Changes in neuropeptide FF and NPY immunohistochemical patterns in rat brain under heroin treatment.
Topics: Animals; Brain; Brain Chemistry; Disease Models, Animal; Heroin; Heroin Dependence; Hypothalamo-Hypophyseal System; Immunohistochemistry; Male; Midline Thalamic Nuclei; Narcotics; Neuropeptide Y; Oligopeptides; Pituitary Gland; Presynaptic Terminals; Rats; Rats, Sprague-Dawley; Septal Nuclei; Solitary Nucleus | 2006 |
Spinal effect of a neuropeptide FF analogue on hyperalgesia and morphine-induced analgesia in mononeuropathic and diabetic rats.
Topics: Analgesia; Analgesics; Analgesics, Opioid; Animals; Behavior, Animal; Diabetes Mellitus, Experimental; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hyperalgesia; Injections, Spinal; Male; Morphine; Naltrexone; Narcotic Antagonists; Nervous System Diseases; Oligopeptides; Pain; Rats; Rats, Sprague-Dawley; Somatostatin; Time Factors; Vocalization, Animal | 1999 |
Effects of (1DMe)NPYF, a synthetic neuropeptide FF analogue, in different pain models.
Topics: Amino Acid Sequence; Analgesics, Non-Narcotic; Animals; Disease Models, Animal; Drug Antagonism; Injections, Spinal; Male; Motor Activity; Naloxone; Oligopeptides; Pain; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley | 1999 |
Identification and characterization of novel mammalian neuropeptide FF-like peptides that attenuate morphine-induced antinociception.
Topics: Amino Acid Sequence; Analgesics; Analgesics, Opioid; Animals; Cells, Cultured; Central Nervous System; CHO Cells; Cricetinae; Disease Models, Animal; Drug Interactions; Humans; Male; Mice; Molecular Sequence Data; Morphine; Oligopeptides; Pain; Pain Measurement; Rats; Rats, Sprague-Dawley; Sequence Homology, Amino Acid | 2001 |